Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection
Clinical trial NCT02452814 · COMPLETED
Trial details
- NCT number
- NCT02452814
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-07
- Primary completion
- 2017-05-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.